trending Market Intelligence /marketintelligence/en/news-insights/trending/mm7czH-kDc45D8XUnXATBg2 content esgSubNav
In This List

Ionis CEO to become executive chairman in 2020

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Ionis CEO to become executive chairman in 2020

Ionis Pharmaceuticals Inc. said founder and CEO Stanley Crooke will transition to executive chairman of the company's board of directors, effective January 2020.

Brett Monia, who has been COO for the previous year and a founding member of Carlsbad, Calif.-based Ionis, will take over from Crooke as CEO.

Crooke will continue to be in charge of board affairs and will provide strategic advice, as well as participate in the scientific activities of the company.

Ionis develops RNA-targeted therapies for genetic diseases such as spinal muscular atrophy, transthyretin amyloidosis and familial chylomicronemia syndrome.